UK markets close in 8 hours 25 minutes

Puma Biotechnology, Inc. (PBYI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.8300-0.3000 (-5.85%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
21,591
21,591
2
-29,126
-59,995
Depreciation & amortisation
11,519
11,519
9,840
11,305
10,033
Stock-based compensation
10,247
10,247
11,826
32,633
36,575
Change in working capital
-17,854
-17,854
-44,496
-1,309
13,160
Accounts receivable
-8,368
-8,368
-7,824
-5,983
2,353
Inventory
-2,554
-2,554
2,583
-3,655
-284
Accounts payable
449
449
-4,734
-902
-7,107
Other working capital
14,369
14,369
-22,827
20,650
-9,273
Other non-cash items
-
-
7,000
-
-
Net cash provided by operating activities
27,009
27,009
-15,827
20,650
773
Cash flows from investing activities
Investments in property, plant and equipment
-12,640
-12,640
-7,000
-
-10,046
Purchases of investments
-23,813
-23,813
-4,836
-38,073
-29,826
Sales/maturities of investments
17,328
17,328
18,940
27,192
73,275
Net cash used for investing activities
-19,125
-19,125
7,104
-10,881
33,403
Cash flows from financing activities
Debt repayment
0
0
0
-100,000
-8,444
Common stock issued
0
0
12,500
0
0
Other financing activities
-
-
-277
-30,431
-10,000
Net cash used provided by (used for) financing activities
0
0
12,223
-31,931
-9,932
Net change in cash
7,884
7,884
3,500
-22,162
24,244
Cash at beginning of period
78,792
78,792
75,292
97,454
73,210
Cash at end of period
86,676
86,676
78,792
75,292
97,454
Free cash flow
Operating cash flow
27,009
27,009
-15,827
20,650
773
Capital expenditure
-12,640
-12,640
-7,000
-
-10,046
Free cash flow
14,369
14,369
-22,827
20,650
-9,273